APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iopromide API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Iopromide API Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchIopromide API Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Iopromide API Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Iopromide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iopromide API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Iopromide API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Iopromide API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Iopromide API's global sales reached XX (K Units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Bayer as the global sales leader, a title it has maintained for several consecutive years. Notably, Bayer's performance in primary markets is also remarkable. In the Chinese market, sales were XX (K Units), a change of XX% from the previous year. In Europe, sales were XX (K Units), showing a year-on-year of XX%. In the US, sales were XX (K Units), a year-on-year change of XX%.

The major global manufacturers in the Iopromide API market include Bayer, Stellite and Haichang Pharmaceutical, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Iopromide API production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Iopromide API by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Iopromide API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Iopromide API, also provides the consumption of main regions and countries. Of the upcoming market potential for Iopromide API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Iopromide API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Iopromide API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Iopromide API sales, projected growth trends, production technology, application and end-user industry.

Iopromide API Segment by Company

Bayer

Stellite

Haichang Pharmaceutical

Iopromide API Segment by Type

Original Drug

Generic Drug

Iopromide API Segment by Application

Hospitals

Clinics

Iopromide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iopromide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iopromide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iopromide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Iopromide API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Iopromide API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Iopromide API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Iopromide API sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Iopromide API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Original Drug Major Manufacturers Table 3. Generic Drug Major Manufacturers Table 4. Global Iopromide API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Iopromide API Industry Trends Table 8. Iopromide API Industry Drivers Table 9. Iopromide API Industry Opportunities and Challenges Table 10. Iopromide API Industry Restraints Table 11. Global Iopromide API Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 12. Global Iopromide API Production by Region (2021-2026) & (K Units) Table 13. Global Iopromide API Production by Region (2027-2032) & (K Units) Table 14. Global Iopromide API Production Market Share by Region (2021-2026) Table 15. Global Iopromide API Production Market Share by Region (2027-2032) Table 16. Global Iopromide API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Iopromide API Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Iopromide API Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Iopromide API Revenue Market Share by Region (2021-2026) Table 20. Global Iopromide API Revenue Market Share by Region (2027-2032) Table 21. Global Iopromide API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Iopromide API Sales by Region (2021-2026) & (K Units) Table 23. Global Iopromide API Sales by Region (2027-2032) & (K Units) Table 24. Global Iopromide API Sales Market Share by Region (2021-2026) Table 25. Global Iopromide API Sales Market Share by Region (2027-2032) Table 26. Global Iopromide API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Iopromide API Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Iopromide API Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Iopromide API Sales Market Share by Manufacturers (2021-2026) Table 30. Global Iopromide API Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Iopromide API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Iopromide API Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Iopromide API Manufacturers, Product Type & Application Table 34. Global Iopromide API Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Iopromide API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Iopromide API Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Iopromide API Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Iopromide API Revenue Market Share by Type (2021-2026) Table 40. Global Iopromide API Revenue Market Share by Type (2027-2032) Table 41. Global Iopromide API Sales by Type (2021-2026) & (K Units) Table 42. Global Iopromide API Sales by Type (2027-2032) & (K Units) Table 43. Global Iopromide API Sales Market Share by Type (2021-2026) Table 44. Global Iopromide API Sales Market Share by Type (2027-2032) Table 45. Global Iopromide API Price by Type (2021-2026) & (US$/Unit) Table 46. Global Iopromide API Price by Type (2027-2032) & (US$/Unit) Table 47. Global Iopromide API Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Iopromide API Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Iopromide API Revenue Market Share by Application (2021-2026) Table 50. Global Iopromide API Revenue Market Share by Application (2027-2032) Table 51. Global Iopromide API Sales by Application (2021-2026) & (K Units) Table 52. Global Iopromide API Sales by Application (2027-2032) & (K Units) Table 53. Global Iopromide API Sales Market Share by Application (2021-2026) Table 54. Global Iopromide API Sales Market Share by Application (2027-2032) Table 55. Global Iopromide API Price by Application (2021-2026) & (US$/Unit) Table 56. Global Iopromide API Price by Application (2027-2032) & (US$/Unit) Table 57. Bayer Company Information Table 58. Bayer Business Overview Table 59. Bayer Iopromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bayer Iopromide API Product Portfolio Table 61. Bayer Recent Development Table 62. Stellite Company Information Table 63. Stellite Business Overview Table 64. Stellite Iopromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Stellite Iopromide API Product Portfolio Table 66. Stellite Recent Development Table 67. Haichang Pharmaceutical Company Information Table 68. Haichang Pharmaceutical Business Overview Table 69. Haichang Pharmaceutical Iopromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Haichang Pharmaceutical Iopromide API Product Portfolio Table 71. Haichang Pharmaceutical Recent Development Table 72. North America Iopromide API Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Iopromide API Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Iopromide API Sales by Type (2021-2026) & (K Units) Table 75. North America Iopromide API Sales by Type (2027-2032) & (K Units) Table 76. North America Iopromide API Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Iopromide API Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Iopromide API Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Iopromide API Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Iopromide API Sales by Application (2021-2026) & (K Units) Table 81. North America Iopromide API Sales by Application (2027-2032) & (K Units) Table 82. North America Iopromide API Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Iopromide API Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Iopromide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Iopromide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Iopromide API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Iopromide API Sales by Country (2021-2026) & (K Units) Table 89. North America Iopromide API Sales by Country (2027-2032) & (K Units) Table 90. North America Iopromide API Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Iopromide API Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Iopromide API Revenue (2021-2032) & (US$ Million) Table 93. Canada Iopromide API Revenue (2021-2032) & (US$ Million) Table 94. Mexico Iopromide API Revenue (2021-2032) & (US$ Million) Table 95. Europe Iopromide API Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Iopromide API Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Iopromide API Sales by Type (2021-2026) & (K Units) Table 98. Europe Iopromide API Sales by Type (2027-2032) & (K Units) Table 99. Europe Iopromide API Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Iopromide API Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Iopromide API Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Iopromide API Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Iopromide API Sales by Application (2021-2026) & (K Units) Table 104. Europe Iopromide API Sales by Application (2027-2032) & (K Units) Table 105. Europe Iopromide API Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Iopromide API Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Iopromide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Iopromide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Iopromide API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Iopromide API Sales by Country (2021-2026) & (K Units) Table 112. Europe Iopromide API Sales by Country (2027-2032) & (K Units) Table 113. Europe Iopromide API Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Iopromide API Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Iopromide API Revenue (2021-2032) & (US$ Million) Table 116. France Iopromide API Revenue (2021-2032) & (US$ Million) Table 117. U.K. Iopromide API Revenue (2021-2032) & (US$ Million) Table 118. Italy Iopromide API Revenue (2021-2032) & (US$ Million) Table 119. Russia Iopromide API Revenue (2021-2032) & (US$ Million) Table 120. Spain Iopromide API Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Iopromide API Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Iopromide API Revenue (2021-2032) & (US$ Million) Table 123. Sweden Iopromide API Revenue (2021-2032) & (US$ Million) Table 124. Poland Iopromide API Revenue (2021-2032) & (US$ Million) Table 125. China Iopromide API Revenue by Type (2021-2026) & (US$ Million) Table 126. China Iopromide API Revenue by Type (2027-2032) & (US$ Million) Table 127. China Iopromide API Sales by Type (2021-2026) & (K Units) Table 128. China Iopromide API Sales by Type (2027-2032) & (K Units) Table 129. China Iopromide API Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Iopromide API Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Iopromide API Revenue by Application (2021-2026) & (US$ Million) Table 132. China Iopromide API Revenue by Application (2027-2032) & (US$ Million) Table 133. China Iopromide API Sales by Application (2021-2026) & (K Units) Table 134. China Iopromide API Sales by Application (2027-2032) & (K Units) Table 135. China Iopromide API Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Iopromide API Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Iopromide API Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Iopromide API Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Iopromide API Sales by Type (2021-2026) & (K Units) Table 140. Asia Iopromide API Sales by Type (2027-2032) & (K Units) Table 141. Asia Iopromide API Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Iopromide API Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Iopromide API Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Iopromide API Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Iopromide API Sales by Application (2021-2026) & (K Units) Table 146. Asia Iopromide API Sales by Application (2027-2032) & (K Units) Table 147. Asia Iopromide API Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Iopromide API Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Iopromide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Iopromide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Iopromide API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Iopromide API Sales by Country (2021-2026) & (K Units) Table 154. Asia Iopromide API Sales by Country (2027-2032) & (K Units) Table 155. Asia Iopromide API Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Iopromide API Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Iopromide API Revenue (2021-2032) & (US$ Million) Table 158. South Korea Iopromide API Revenue (2021-2032) & (US$ Million) Table 159. India Iopromide API Revenue (2021-2032) & (US$ Million) Table 160. Australia Iopromide API Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Iopromide API Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Iopromide API Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Iopromide API Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Iopromide API Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Iopromide API Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Iopromide API Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Iopromide API Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Iopromide API Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Iopromide API Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Iopromide API Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Iopromide API Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Iopromide API Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Iopromide API Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Iopromide API Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Iopromide API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Iopromide API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Iopromide API Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Iopromide API Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Iopromide API Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Iopromide API Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Iopromide API Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Iopromide API Revenue (2021-2032) & (US$ Million) Table 184. Argentina Iopromide API Revenue (2021-2032) & (US$ Million) Table 185. Chile Iopromide API Revenue (2021-2032) & (US$ Million) Table 186. Colombia Iopromide API Revenue (2021-2032) & (US$ Million) Table 187. Peru Iopromide API Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Iopromide API Revenue (2021-2032) & (US$ Million) Table 189. Israel Iopromide API Revenue (2021-2032) & (US$ Million) Table 190. UAE Iopromide API Revenue (2021-2032) & (US$ Million) Table 191. Turkey Iopromide API Revenue (2021-2032) & (US$ Million) Table 192. Iran Iopromide API Revenue (2021-2032) & (US$ Million) Table 193. Egypt Iopromide API Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Iopromide API Distributors List Table 197. Iopromide API Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Iopromide API Product Image Figure 2. Global Iopromide API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iopromide API Market Size Share 2021 VS 2025 VS 2032 Figure . Original Drug Image Figure 1. Generic Drug Image Figure 2. Global Iopromide API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iopromide API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospitals Image Figure 5. Clinics Image Figure 6. Global Iopromide API Capacity, Capacity Utilization (2021-2032) & (K Units) Figure 7. Global Iopromide API Production by Region: 2021 VS 2025 VS 2032 (K Units) Figure 8. Global Iopromide API Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Iopromide API Production Market Share by Region (2021-2032) Figure 10. North America Iopromide API Production Growth Rate (2021-2032) & (K Units) Figure 11. Europe Iopromide API Production Growth Rate (2021-2032) & (K Units) Figure 12. China Iopromide API Production Growth Rate (2021-2032) & (K Units) Figure 13. Japan Iopromide API Production Growth Rate (2021-2032) & (K Units) Figure 14. South Korea Iopromide API Production Growth Rate (2021-2032) & (K Units) Figure 15. India Iopromide API Production Growth Rate (2021-2032) & (K Units) Figure 16. Global Iopromide API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Iopromide API Revenue (2021-2032) & (US$ Million) Figure 18. Global Iopromide API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Iopromide API Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Iopromide API Revenue Market Share by Region (2021-2032) Figure 21. Global Iopromide API Sales (2021-2032) & (K Units) Figure 22. Global Iopromide API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Iopromide API Sales Market Share by Region (2021-2032) Figure 24. North America Iopromide API Sales YoY (2021-2032) & (K Units) Figure 25. Europe Iopromide API Sales YoY (2021-2032) & (K Units) Figure 26. China Iopromide API Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Iopromide API Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Iopromide API Sales YoY (2021-2032) & (K Units) Figure 29. Global Iopromide API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Iopromide API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Iopromide API Revenue Market Share by Type (2021-2032) Figure 33. Global Iopromide API Sales Market Share by Type (2021-2032) Figure 34. Global Iopromide API Revenue Market Share by Application (2021-2032) Figure 35. Global Iopromide API Sales Market Share by Application (2021-2032) Figure 36. North America Iopromide API Revenue Share by Type (2021-2032) Figure 37. North America Iopromide API Sales Share by Type (2021-2032) Figure 38. North America Iopromide API Revenue Share by Application (2021-2032) Figure 39. North America Iopromide API Sales Share by Application (2021-2032) Figure 40. North America Iopromide API Revenue Share by Country (2021-2032) Figure 41. North America Iopromide API Sales Share by Country (2021-2032) Figure 42. Europe Iopromide API Revenue Share by Type (2021-2032) Figure 43. Europe Iopromide API Sales Share by Type (2021-2032) Figure 44. Europe Iopromide API Revenue Share by Application (2021-2032) Figure 45. Europe Iopromide API Sales Share by Application (2021-2032) Figure 46. Europe Iopromide API Revenue Share by Country (2021-2032) Figure 47. Europe Iopromide API Sales Share by Country (2021-2032) Figure 48. China Iopromide API Revenue Share by Type (2021-2032) Figure 49. China Iopromide API Sales Share by Type (2021-2032) Figure 50. China Iopromide API Revenue Share by Application (2021-2032) Figure 51. China Iopromide API Sales Share by Application (2021-2032) Figure 52. Asia Iopromide API Revenue Share by Type (2021-2032) Figure 53. Asia Iopromide API Sales Share by Type (2021-2032) Figure 54. Asia Iopromide API Revenue Share by Application (2021-2032) Figure 55. Asia Iopromide API Sales Share by Application (2021-2032) Figure 56. Asia Iopromide API Revenue Share by Country (2021-2032) Figure 57. Asia Iopromide API Sales Share by Country (2021-2032) Figure 58. SAMEA Iopromide API Revenue Share by Type (2021-2032) Figure 59. SAMEA Iopromide API Sales Share by Type (2021-2032) Figure 60. SAMEA Iopromide API Revenue Share by Application (2021-2032) Figure 61. SAMEA Iopromide API Sales Share by Application (2021-2032) Figure 62. SAMEA Iopromide API Revenue Share by Country (2021-2032) Figure 63. SAMEA Iopromide API Sales Share by Country (2021-2032) Figure 64. Iopromide API Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Iopromide API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospitals
  • Clinics
Companies covered
  • Bayer
  • Stellite
  • Haichang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Iopromide API Market by Type
  3. 1.2.1 Global Iopromide API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Original Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Iopromide API Market by Application
  7. 1.3.1 Global Iopromide API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Iopromide API Market Dynamics
  1. 2.1 Iopromide API Industry Trends
  2. 2.2 Iopromide API Industry Drivers
  3. 2.3 Iopromide API Industry Opportunities and Challenges
  4. 2.4 Iopromide API Industry Restraints
3 Global Iopromide API Production Overview
  1. 3.1 Global Iopromide API Production Capacity (2021-2032)
  2. 3.2 Global Iopromide API Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Iopromide API Production by Region
  4. 3.3.1 Global Iopromide API Production by Region (2021-2026)
  5. 3.3.2 Global Iopromide API Production by Region (2027-2032)
  6. 3.3.3 Global Iopromide API Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
  11. 3.8 South Korea
  12. 3.9 India
4 Global Market Growth Prospects
  1. 4.1 Global Iopromide API Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Iopromide API Revenue by Region
  3. 4.2.1 Global Iopromide API Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Iopromide API Revenue by Region (2021-2026)
  5. 4.2.3 Global Iopromide API Revenue by Region (2027-2032)
  6. 4.2.4 Global Iopromide API Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Iopromide API Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Iopromide API Sales by Region
  9. 4.4.1 Global Iopromide API Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Iopromide API Sales by Region (2021-2026)
  11. 4.4.3 Global Iopromide API Sales by Region (2027-2032)
  12. 4.4.4 Global Iopromide API Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Iopromide API Revenue by Manufacturers
  2. 5.1.1 Global Iopromide API Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Iopromide API Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Iopromide API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Iopromide API Sales by Manufacturers
  6. 5.2.1 Global Iopromide API Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Iopromide API Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Iopromide API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Iopromide API Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Iopromide API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Iopromide API Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Iopromide API Manufacturers, Product Type & Application
  13. 5.7 Global Iopromide API Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Iopromide API Market CR5 and HHI
  16. 5.8.2 2025 Iopromide API Tier 1, Tier 2, and Tier 3
6 Iopromide API Market by Type
  1. 6.1 Global Iopromide API Revenue by Type
  2. 6.1.1 Global Iopromide API Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Iopromide API Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Iopromide API Sales by Type
  5. 6.2.1 Global Iopromide API Sales by Type (2021-2032) & (K Units)
  6. 6.2.2 Global Iopromide API Sales Market Share by Type (2021-2032)
  7. 6.3 Global Iopromide API Price by Type
7 Iopromide API Market by Application
  1. 7.1 Global Iopromide API Revenue by Application
  2. 7.1.1 Global Iopromide API Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Iopromide API Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Iopromide API Sales by Application
  5. 7.2.1 Global Iopromide API Sales by Application (2021-2032) & (K Units)
  6. 7.2.2 Global Iopromide API Sales Market Share by Application (2021-2032)
  7. 7.3 Global Iopromide API Price by Application
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Iopromide API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Iopromide API Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Stellite
  8. 8.2.1 Stellite Company Information
  9. 8.2.2 Stellite Business Overview
  10. 8.2.3 Stellite Iopromide API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Stellite Iopromide API Product Portfolio
  12. 8.2.5 Stellite Recent Developments
  13. 8.3 Haichang Pharmaceutical
  14. 8.3.1 Haichang Pharmaceutical Company Information
  15. 8.3.2 Haichang Pharmaceutical Business Overview
  16. 8.3.3 Haichang Pharmaceutical Iopromide API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Haichang Pharmaceutical Iopromide API Product Portfolio
  18. 8.3.5 Haichang Pharmaceutical Recent Developments
9 North America
  1. 9.1 North America Iopromide API Market Size by Type
  2. 9.1.1 North America Iopromide API Revenue by Type (2021-2032)
  3. 9.1.2 North America Iopromide API Sales by Type (2021-2032)
  4. 9.1.3 North America Iopromide API Price by Type (2021-2032)
  5. 9.2 North America Iopromide API Market Size by Application
  6. 9.2.1 North America Iopromide API Revenue by Application (2021-2032)
  7. 9.2.2 North America Iopromide API Sales by Application (2021-2032)
  8. 9.2.3 North America Iopromide API Price by Application (2021-2032)
  9. 9.3 North America Iopromide API Market Size by Country
  10. 9.3.1 North America Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Iopromide API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Iopromide API Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Iopromide API Market Size by Type
  2. 10.1.1 Europe Iopromide API Revenue by Type (2021-2032)
  3. 10.1.2 Europe Iopromide API Sales by Type (2021-2032)
  4. 10.1.3 Europe Iopromide API Price by Type (2021-2032)
  5. 10.2 Europe Iopromide API Market Size by Application
  6. 10.2.1 Europe Iopromide API Revenue by Application (2021-2032)
  7. 10.2.2 Europe Iopromide API Sales by Application (2021-2032)
  8. 10.2.3 Europe Iopromide API Price by Application (2021-2032)
  9. 10.3 Europe Iopromide API Market Size by Country
  10. 10.3.1 Europe Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Iopromide API Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Iopromide API Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Iopromide API Market Size by Type
  2. 11.1.1 China Iopromide API Revenue by Type (2021-2032)
  3. 11.1.2 China Iopromide API Sales by Type (2021-2032)
  4. 11.1.3 China Iopromide API Price by Type (2021-2032)
  5. 11.2 China Iopromide API Market Size by Application
  6. 11.2.1 China Iopromide API Revenue by Application (2021-2032)
  7. 11.2.2 China Iopromide API Sales by Application (2021-2032)
  8. 11.2.3 China Iopromide API Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Iopromide API Market Size by Type
  2. 12.1.1 Asia Iopromide API Revenue by Type (2021-2032)
  3. 12.1.2 Asia Iopromide API Sales by Type (2021-2032)
  4. 12.1.3 Asia Iopromide API Price by Type (2021-2032)
  5. 12.2 Asia Iopromide API Market Size by Application
  6. 12.2.1 Asia Iopromide API Revenue by Application (2021-2032)
  7. 12.2.2 Asia Iopromide API Sales by Application (2021-2032)
  8. 12.2.3 Asia Iopromide API Price by Application (2021-2032)
  9. 12.3 Asia Iopromide API Market Size by Country
  10. 12.3.1 Asia Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Iopromide API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Iopromide API Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Iopromide API Market Size by Type
  2. 13.1.1 SAMEA Iopromide API Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Iopromide API Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Iopromide API Price by Type (2021-2032)
  5. 13.2 SAMEA Iopromide API Market Size by Application
  6. 13.2.1 SAMEA Iopromide API Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Iopromide API Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Iopromide API Price by Application (2021-2032)
  9. 13.3 SAMEA Iopromide API Market Size by Country
  10. 13.3.1 SAMEA Iopromide API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Iopromide API Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Iopromide API Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Iopromide API Value Chain Analysis
  2. 14.1.1 Iopromide API Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Iopromide API Production Mode & Process
  6. 14.2 Iopromide API Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Iopromide API Distributors
  9. 14.2.3 Iopromide API Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst